skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sequential NMR resonance assignment and structure determination of the Kunitz-type inhibitor domain of the Alzheimer's. beta. -amyloid precursor protein

Journal Article · · Biochemistry; (United States)
DOI:https://doi.org/10.1021/bi00107a015· OSTI ID:5616215
;  [1]; ; ; ; ; ; ; ; ;  [2]
  1. Miles, Inc., West Haven, CT (United States)
  2. Molecular Therapeutics, Inc., West Haven, CT (United States)

Certain precursor proteins (APP{sub 751} and APP{sub 770}) of the amyloid {beta}-protein (AP) present in Alzheimer's disease contain a Kunitz-type serine protease inhibitor domain (APPI). In this study, the domain is obtained as a functional inhibitor through both recombinant (APPI{sub r}) and synthetic (APPI{sub s}) methodologies, and the solution structure of APPI is determined by {sup 1}H 2D NMR techniques. Complete sequence-specific resonance assignments (except for P13 and G37 NH) for both APPI{sub r} and APPI{sub s} are achieved using standard procedures. Ambiguities arising from degeneracies in the NMR resonances are resolved by varying sample conditions. Qualitative interpretation of short- and long-range NOEs reveals secondary structural features similar to those extensively documented by NMR for bovine pancreatic trypsin inhibitor (BPTI). A more rigorous interpretation of the NOESY spectra yields NOE-derived interresidue distance restraints which are used in conjunction with dynamic simulated annealing to generate a family of APPI structures. Within this family, the {beta}-sheet and helical regions are in good agreement with the crystal structure of BPTI, whereas portions of the protease-binding loops deviate from those in BPTI. These deviations are consistent with those recently described in the crystal structure of APPI.

OSTI ID:
5616215
Journal Information:
Biochemistry; (United States), Vol. 30:43; ISSN 0006-2960
Country of Publication:
United States
Language:
English